{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jimoh TO"],"funding":["Thailand Science Research and Innovation Fund Chulalongkorn University"],"pagination":["7902"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9699248"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["27(22)"],"pubmed_abstract":["The most prevalent lung cancer is non-small cell lung cancer (NSCLC). This lung cancer type often develops other organ-specific metastases that are critical burdens in the treatment process. Orchid species in the genus <i>Vanda</i> have shown their potential in folkloric medication of diverse diseases but not all its species have been investigated, and little is known about their anticancer activities against NSCLC. Here, we firstly profiled the specialized metabolites of <i>Vanda&amp;nbsp;bensonii</i> and examined their capability to inhibit growth and metastasis of NSCLC using NCI-H460 cells as a study model. Four phytochemicals, including phloretic acid methyl ester (<b>1</b>), cymbinodin-A (<b>2</b>), ephemeranthoquinone B (<b>3</b>), and protocatechuic acid (<b>4</b>), were isolated f"],"journal":["Molecules (Basel, Switzerland)"],"pubmed_title":["Phytochemicals from <i>Vanda&amp;nbsp;bensonii</i> and Their Bioactivities to Inhibit Growth and Metastasis of Non-Small Cell Lung Cancer Cells."],"pmcid":["PMC9699248"],"funding_grant_id":["CU_FRB65_hea (57)066_33_10 and CU_FRB65_hea (60)069_33_13"],"pubmed_authors":["Likhitwitayawuid K","Chansriniyom C","Chaotham C","Chanvorachote P","Jimoh TO","Nuamnaichati N","Sritularak B","Sungthong R"],"additional_accession":[]},"is_claimable":false,"name":"Phytochemicals from <i>Vanda&amp;nbsp;bensonii</i> and Their Bioactivities to Inhibit Growth and Metastasis of Non-Small Cell Lung Cancer Cells.","description":"The most prevalent lung cancer is non-small cell lung cancer (NSCLC). This lung cancer type often develops other organ-specific metastases that are critical burdens in the treatment process. Orchid species in the genus <i>Vanda</i> have shown their potential in folkloric medication of diverse diseases but not all its species have been investigated, and little is known about their anticancer activities against NSCLC. Here, we firstly profiled the specialized metabolites of <i>Vanda&amp;nbsp;bensonii</i> and examined their capability to inhibit growth and metastasis of NSCLC using NCI-H460 cells as a study model. Four phytochemicals, including phloretic acid methyl ester (<b>1</b>), cymbinodin-A (<b>2</b>), ephemeranthoquinone B (<b>3</b>), and protocatechuic acid (<b>4</b>), were isolated f","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-26T05:17:15.646Z","creation":"2025-04-06T11:27:17.632Z"},"accession":"S-EPMC9699248","cross_references":{"pubmed":["36432003"],"doi":["10.3390/molecules27227902"]}}